跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Hepliv - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Hepliv
Approved
STANDARD
Hepliv
Bharat Biotech International Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
09b05556bafd81e1
Company
Bharat Biotech International Ltd.
Type
Standard
Approval Details
Approval Id
09b05556bafd81e1
Drug Approval Philippines Name
Hepliv
Product Name
Hepliv
Registration Number
BR-502
Brand Name
Hepliv
Generic Name
Hepatitis B Vaccine (rdna)
Dosage Form
Suspension for IM Injection
Dosage Strength
100mcg/ 0.5mL
Manufacturer
Bharat Biotech International Ltd.
Importer
PHIL PHARMAWEALTH, INC.
Distributor
PHIL PHARMAWEALTH, INC.
Company Detail Path
/organization/bharat-biotech-international-ltd
Issuance Date
13 October 2021
Expiry Date
09 October 2026
Pharmacologic Category
Vaccine
Classification
Prescription Drug (Rx)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
09b05556bafd81e1
Type
Standard
Back to Philippines FDA Approvals